This is to notify all that we have begun joint clinical research into nematode cancer detection (N-NOSE) of primary hepatic cancer, together with Tokyo University.
Regarding N-NOSE, both parties are considering whether it is possible to predict the effects of surgery, postoperative recurrence, and the prognosis by evaluating and reviewing the treatment of primary hepatic cancer and the progress following said treatment.
TOKYO, JAPAN – March 6, 2026 – HIROTSU Bio Science Inc. announced the establishment of a new U.S. subsidiary, Hirotsu Global Inc., effectively c . . .
2026.03.06FOR IMMEDIATE RELEASE HIROTSU Bio Science Announces Referral of Former Employee to Prosecutors for Violation of the Unfair Competition Preven . . .
2026.02.05A novel, non-invasive approach to detecting micro-distant metastasis in highly lethal pancreatic cancer. TOKYO, JAPAN – January 5, 2026 – HIR . . .
2026.01.05